Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Human MTHFR-C677T gene transition increased risk of Alzheimer disease: a case-control study which performed by optimized PCR-CTPP method

Human MTHFR-C677T gene transition increased risk of Alzheimer disease: a case-control study which... Methylenetetrahydrofolate reductase (MTHFR) is a gene involved in folate metabolism which may contribute to the risk of Alzheimer disease (AD). In this paper, an association of MTHFR-C677T single nucleotide polymorphism (SNP) with the AD was evaluated by optimized PCR-confronting two-pair primers (PCR-CTPP) genotyping method. For this aim at first, PCR-CTPP method was optimized for detection of this SNP by additive agents and touchdown PCR. Then, an association of the mentioned SNP with the AD was assessed in a case-control study comprising 113 Alzheimer’s patients and 123 controls. Genotyping results showed that additive agents and touchdown PCR are two appropriate strategies for optimization of CTPP method. Our case-control study indicated a significant association between CT genotype (OR = 1.78, 95%CI = 1.04–3.03, p = 0.0357) and T allele (OR = 1.79, 95%CI = 1.07–2.10, p = 0.0273) with AD. Also, MTHFR-C677T polymorphism is associated with AD in a dominant model (OR = 1.79, 95%CI = 1.07–2.10, p = 0.0273). These results recommend that MTHFR-C677T polymorphism increases the risk of Alzheimer disease and can be a biomarker in the screening of this disease. And genotyping of aforementioned SNP could be performed by optimized PCR-CTPP a time-saving and reliable method. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Comparative Clinical Pathology Springer Journals

Human MTHFR-C677T gene transition increased risk of Alzheimer disease: a case-control study which performed by optimized PCR-CTPP method

Download PDF
7 pages

Loading next page...
 
/lp/springer-journals/human-mthfr-c677t-gene-transition-increased-risk-of-alzheimer-disease-MKw0tJX5WI

References (37)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer-Verlag London Ltd., part of Springer Nature
Subject
Medicine & Public Health; Pathology; Hematology; Oncology
eISSN
1618-565X
DOI
10.1007/s00580-018-2676-7
Publisher site
See Article on Publisher Site

Abstract

Methylenetetrahydrofolate reductase (MTHFR) is a gene involved in folate metabolism which may contribute to the risk of Alzheimer disease (AD). In this paper, an association of MTHFR-C677T single nucleotide polymorphism (SNP) with the AD was evaluated by optimized PCR-confronting two-pair primers (PCR-CTPP) genotyping method. For this aim at first, PCR-CTPP method was optimized for detection of this SNP by additive agents and touchdown PCR. Then, an association of the mentioned SNP with the AD was assessed in a case-control study comprising 113 Alzheimer’s patients and 123 controls. Genotyping results showed that additive agents and touchdown PCR are two appropriate strategies for optimization of CTPP method. Our case-control study indicated a significant association between CT genotype (OR = 1.78, 95%CI = 1.04–3.03, p = 0.0357) and T allele (OR = 1.79, 95%CI = 1.07–2.10, p = 0.0273) with AD. Also, MTHFR-C677T polymorphism is associated with AD in a dominant model (OR = 1.79, 95%CI = 1.07–2.10, p = 0.0273). These results recommend that MTHFR-C677T polymorphism increases the risk of Alzheimer disease and can be a biomarker in the screening of this disease. And genotyping of aforementioned SNP could be performed by optimized PCR-CTPP a time-saving and reliable method.

Journal

Comparative Clinical Pathology – Springer Journals

Published: Mar 8, 2018

There are no references for this article.